Ensysce Biosciences Inc Cash Flow Reinvestment Rate

Latest as of March 2020: 0.99x

Ensysce Biosciences Inc cash flow reinvestment rate. Ensysce Biosciences Inc (ENSC) has a Cash Flow Reinvestment Rate of 0.99x as of March 2020, reinvesting $134.62 Million (capex $4.00 plus investments $134.62 Million) from operating cash flow of $136.09 Million. Explore Ensysce Biosciences Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.99x

(Capex + Investments) / Operating CF

Total Reinvested

$134.62 Million

Capex + Investments

Operating Cash Flow

$136.09 Million

USD

Capital Expenditures

$4.00

USD

Cash Flow Reinvestment Rate of Ensysce Biosciences Inc (2019–2019)

Cash flow reinvestment rate of Ensysce Biosciences Inc from 2019 to 2019. Historical reinvestment intensity for Ensysce Biosciences Inc across 1 annual periods. Explore Ensysce Biosciences Inc (ENSC) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Ensysce Biosciences Inc Cash Flow Reinvestment Rate by Year (2019–2019)

Ensysce Biosciences Inc cash flow reinvestment rate by year from 2019 to 2019. Year-by-year capital reinvestment analysis for Ensysce Biosciences Inc. For the full cash flow conversion analysis, see Ensysce Biosciences Inc cash conversion from operations.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2019	1.08x	$11.85 Million	$10.99 Million	$4.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow